• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性淋巴细胞亚群与肝细胞癌之间的关联。

Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma.

作者信息

Guo Cun-Li, Yang Hai-Chao, Yang Xiu-Hua, Cheng Wen, Dong Tian-Xiu, Zhu Wen-Jing, Xu Zheng, Zhao Liang

机构信息

The Third Hospital of Harbin Medical University, Harbin, China.

出版信息

Asian Pac J Cancer Prev. 2012;13(11):5909-13. doi: 10.7314/apjcp.2012.13.11.5909.

DOI:10.7314/apjcp.2012.13.11.5909
PMID:23317279
Abstract

AIMS

We aimed to analyze the phenotype of tumor-infiltrating lymphocytes (TILs) and non-tumor infiltrating lymphocytes (NILs) in HCC and non-tumor tissues, and evaluate relationships between changes in these cells and the prognosis of HCC.

METHODS

Lymphocytes were isolated from HCC and corresponding non-tumor tissues and tested by flow cytometry. For comparison, clinical parameters were analyzed.

RESULTS

Compared with the non-tumor tissue, tumor tissue had a lower intensity of NK, NKT and CD8+T cell infiltration. TILs had higher intensity of CD4+CD25+Foxp3+regulatory T cell (Treg cells) infiltration compared with that in NILs. The prevalence of Treg cells was associated with fewer CD8 + T lymphocytes in the HCC immune microenvironment. The frequencies of NK cells and CD8+T cells in TILs of HCC patients with metastasis less than 12 months were lower than those without metastasis. However, the frequency of Treg cells was higher than those without metastasis.

CONCLUSION

These results suggest that the frequencies of CD8+T, NK and NKT cells as well as Treg cells in the tumor tissue of HCC are significantly associated with patient survival, and could be applied as predictive indicators for HCC prognosis.

摘要

目的

我们旨在分析肝癌组织及非肿瘤组织中肿瘤浸润淋巴细胞(TILs)和非肿瘤浸润淋巴细胞(NILs)的表型,并评估这些细胞变化与肝癌预后之间的关系。

方法

从肝癌组织及相应的非肿瘤组织中分离淋巴细胞,并用流式细胞术进行检测。为作比较,分析了临床参数。

结果

与非肿瘤组织相比,肿瘤组织中自然杀伤细胞(NK)、自然杀伤T细胞(NKT)和CD8⁺T细胞浸润强度较低。与NILs相比,TILs中CD4⁺CD25⁺Foxp3⁺调节性T细胞(Treg细胞)浸润强度更高。在肝癌免疫微环境中,Treg细胞的存在与CD8⁺T淋巴细胞数量减少有关。转移时间小于12个月的肝癌患者TILs中NK细胞和CD8⁺T细胞的频率低于无转移患者。然而,Treg细胞的频率高于无转移患者。

结论

这些结果表明,肝癌肿瘤组织中CD8⁺T细胞、NK细胞、NKT细胞以及Treg细胞的频率与患者生存显著相关,可作为肝癌预后的预测指标。

相似文献

1
Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma.浸润性淋巴细胞亚群与肝细胞癌之间的关联。
Asian Pac J Cancer Prev. 2012;13(11):5909-13. doi: 10.7314/apjcp.2012.13.11.5909.
2
Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.肝细胞癌小鼠中Foxp3 + 调节性T细胞频率增加。
Asian Pac J Cancer Prev. 2012;13(8):3815-9. doi: 10.7314/apjcp.2012.13.8.3815.
3
Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.基于 FoxP3+调节性 T 细胞主要决定的两个 Cox 模型预测肝细胞癌的复发和生存。
Cancer Prev Res (Phila). 2013 Jun;6(6):594-602. doi: 10.1158/1940-6207.CAPR-12-0379. Epub 2013 Apr 18.
4
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.调节性T细胞增多与肝细胞癌患者的CD8 T细胞损伤及生存率低相关。
Gastroenterology. 2007 Jun;132(7):2328-39. doi: 10.1053/j.gastro.2007.03.102. Epub 2007 Apr 14.
5
Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.功能受损的淋巴细胞浸润肝细胞癌:调节性T细胞的作用
Hepatology. 2005 Apr;41(4):722-30. doi: 10.1002/hep.20644.
6
Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.在肝癌患者中,肝浸润的 CD8+FoxP3+调节性 T 细胞增多与肿瘤分期相关。
Hum Immunol. 2010 Dec;71(12):1180-6. doi: 10.1016/j.humimm.2010.09.011. Epub 2010 Sep 24.
7
Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.肝细胞癌中肿瘤浸润淋巴细胞的表型分析
Hepatogastroenterology. 2007 Jul-Aug;54(77):1529-33.
8
Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.在肝癌患者中,CD4(+) CD69(+) CD25(-) T 细胞的增加与肿瘤进展有关。
J Gastroenterol Hepatol. 2011 Oct;26(10):1519-26. doi: 10.1111/j.1440-1746.2011.06765.x.
9
Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.肿瘤浸润的 FoxP3+ Tregs 和 CD8+ T 细胞影响肝癌患者的预后。
Digestion. 2012;86(4):329-37. doi: 10.1159/000342801. Epub 2012 Nov 28.
10
Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.肝移植后肿瘤淋巴细胞浸润与肝细胞癌复发
J Hepatol. 2006 Aug;45(2):246-53. doi: 10.1016/j.jhep.2005.12.027. Epub 2006 Feb 28.

引用本文的文献

1
Targeted immune cell therapy for hepatocellular carcinoma using expanded liver mononuclear cell-derived natural killer cells.使用扩增的肝单个核细胞来源的自然杀伤细胞进行肝细胞癌的靶向免疫细胞治疗。
Neoplasia. 2024 Dec;58:101061. doi: 10.1016/j.neo.2024.101061. Epub 2024 Oct 1.
2
The sorafenib resistance-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.索拉非尼耐药相关基因特征可预测肝细胞癌的预后并提示免疫活性。
Cell Cycle. 2024 Jan;23(2):150-168. doi: 10.1080/15384101.2024.2309020. Epub 2024 Mar 5.
3
: Novel Insight into Hepatoprotective Potential with Mechanisms of Action.
: 具有作用机制的肝保护潜力的新见解。
Nutrients. 2023 Apr 13;15(8):1874. doi: 10.3390/nu15081874.
4
The regulation roles of miRNAs in Helicobacter pylori infection.miRNAs 在幽门螺杆菌感染中的调控作用。
Clin Transl Oncol. 2023 Jul;25(7):1929-1939. doi: 10.1007/s12094-023-03094-9. Epub 2023 Feb 13.
5
Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio.基于中性粒细胞与淋巴细胞比值的术后辅助经动脉化疗栓塞术的治疗效果
Front Surg. 2023 Jan 6;9:1072451. doi: 10.3389/fsurg.2022.1072451. eCollection 2022.
6
A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma.局部晚期肝细胞癌患者肝动脉灌注化疗联合局部高剂量自体自然杀伤细胞治疗的 I 期研究。
Front Immunol. 2022 Jun 2;13:879452. doi: 10.3389/fimmu.2022.879452. eCollection 2022.
7
Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.鉴定免疫浸润相关基因作为肝细胞癌的预后指标。
BMC Cancer. 2022 May 5;22(1):496. doi: 10.1186/s12885-022-09587-0.
8
Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.肝细胞癌的肿瘤微环境:新治疗方案面临的挑战与机遇
Int J Mol Sci. 2022 Mar 29;23(7):3778. doi: 10.3390/ijms23073778.
9
Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.肝细胞癌中的自然杀伤细胞和1型先天性淋巴细胞:当前认知与未来展望
Int J Mol Sci. 2021 Aug 22;22(16):9044. doi: 10.3390/ijms22169044.
10
Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.基于自然杀伤细胞的免疫疗法与不可逆电穿孔联合治疗肝细胞癌
Ann Transl Med. 2021 Jul;9(13):1089. doi: 10.21037/atm-21-539.